Omar S. Qureshi, Emma J. Sutton, Rosemary F. Bithell, Shauna M. West, Rona M. Cutler, Gillian McCluskey, . . . Anthony Shock. (2024). Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro. Taylor & Francis Group.
Chicago Style (17th ed.) CitationOmar S. Qureshi, et al. Interactions of the Anti-FcRn Monoclonal Antibody, Rozanolixizumab, with Fcγ Receptors and Functional Impact on Immune Cells in Vitro. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationOmar S. Qureshi, et al. Interactions of the Anti-FcRn Monoclonal Antibody, Rozanolixizumab, with Fcγ Receptors and Functional Impact on Immune Cells in Vitro. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.